Neuralstem - Stock Price History | CUR

Historical daily share price chart and data for Neuralstem since 2019 adjusted for splits. The latest closing stock price for Neuralstem as of September 20, 2019 is 1.69.
  • The all-time high Neuralstem stock closing price was 1211.96 on April 09, 2014.
  • The Neuralstem 52-week high stock price is 24.40, which is 1343.8% above the current share price.
  • The Neuralstem 52-week low stock price is 1.50, which is 11.2% below the current share price.
  • The average Neuralstem stock price for the last 52 weeks is 8.78.
Neuralstem Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 25.6266 40.6000 42.8000 6.2620 6.2620 -81.80%
2017 64.3126 80.8843 126.6000 18.7560 34.4000 -51.62%
2016 119.8060 267.8804 280.8843 51.8856 71.1053 -73.46%
2015 497.2444 730.8192 996.0988 262.6788 267.8804 -62.13%
2014 897.0834 821.8466 1211.9636 616.3849 707.4122 -6.53%
2013 447.0554 314.6944 764.6294 270.4811 756.8270 166.97%
2012 264.2239 260.0780 387.5163 117.0351 283.4850 12.95%
2011 387.2409 564.3693 590.3771 231.4694 250.9753 -54.48%
2010 608.3102 481.1443 894.6684 468.1404 551.3654 18.44%
2009 343.8505 434.3303 540.9623 208.0624 465.5397 8.68%
2008 509.1591 951.8856 951.8856 280.8583 428.3485 -55.84%
2007 793.0096 832.2497 1050.7152 582.5748 970.0910 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.004B $0.000B
NEURALSTEM's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.332B 13.36
Gilead Sciences (GILD) United States $83.535B 10.26
CSL (CSLLY) Australia $72.754B 0.00
Celgene (CELG) United States $70.130B 10.85
Vertex Pharmaceuticals (VRTX) United States $45.274B 48.93
Illumina (ILMN) United States $44.864B 52.71
Biogen (BIIB) United States $43.459B 7.72
Regeneron Pharmaceuticals (REGN) United States $31.428B 14.27
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.694B 12.49
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.801B 49.44
BioMarin Pharmaceutical (BMRN) United States $13.639B 0.00
Exact Sciences (EXAS) United States $13.389B 0.00
Genmab (GNMSF) Denmark $12.505B 70.14
Seattle Genetics (SGEN) United States $11.770B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.408B 0.00
Galapagos (GLPG) Belgium $8.713B 0.00
QIAGEN (QGEN) Netherlands $7.627B 25.05
Bio-Techne Corp (TECH) United States $7.484B 51.70
Guardant Health (GH) United States $6.751B 0.00
Sarepta Therapeutics (SRPT) United States $6.346B 0.00
BeiGene (BGNE) Cayman Islands $6.313B 0.00
Amarin (AMRN) Ireland $6.051B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.022B 0.00
Exelixis (EXEL) United States $5.928B 15.41
Moderna (MRNA) United States $5.910B 0.00
Bluebird Bio (BLUE) United States $5.863B 0.00
Horizon Pharma Public (HZNP) Ireland $4.941B 12.56
ARGENX SE-ADR (ARGX) Netherlands $4.817B 0.00
Ascendis Pharma (ASND) Denmark $4.538B 0.00
China Biologic Products (CBPO) China $4.487B 28.01
Repligen (RGEN) United States $4.247B 82.41
Spark Therapeutics (ONCE) United States $3.926B 0.00
Blueprint Medicines (BPMC) United States $3.900B 0.00
Medicines (MDCO) United States $3.824B 0.00
MorphoSys AG (MOR) Germany $3.702B 0.00
Mirati Therapeutics (MRTX) United States $3.615B 0.00
Alkermes (ALKS) Ireland $3.334B 0.00
Immunomedics (IMMU) United States $3.273B 0.00
Reata Pharmaceuticals (RETA) United States $2.764B 0.00
Emergent Biosolutions (EBS) United States $2.686B 40.35
MyoKardia (MYOK) United States $2.668B 0.00
Genomic Health (GHDX) United States $2.640B 49.51
CRISPR Therapeutics AG (CRSP) Switzerland $2.597B 0.00
Arena Pharmaceuticals (ARNA) United States $2.551B 5.48
Ultragenyx Pharmaceutical (RARE) United States $2.502B 0.00
Amicus Therapeutics (FOLD) United States $2.450B 0.00
Halozyme Therapeutics (HALO) United States $2.383B 0.00
Acceleron Pharma (XLRN) United States $2.281B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.264B 0.00
NeoGenomics (NEO) United States $2.263B 121.06
Akcea Therapeutics (AKCA) United States $2.090B 0.00
Myriad Genetics (MYGN) United States $2.066B 21.68
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.995B 0.00
Ligand Pharmaceuticals (LGND) United States $1.990B 25.17
UniQure (QURE) Netherlands $1.795B 0.00
Denali Therapeutics (DNLI) United States $1.745B 0.00
Insmed (INSM) United States $1.742B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.621B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.561B 0.00
REGENXBIO (RGNX) United States $1.451B 0.00
Coherus BioSciences (CHRS) United States $1.435B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.395B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.315B 0.00
Alector (ALEC) United States $1.273B 0.00
Editas Medicine (EDIT) United States $1.247B 0.00
Sangamo Therapeutics (SGMO) United States $1.230B 0.00
RA PHARMCTL INC (RARX) United States $1.183B 0.00
Fate Therapeutics (FATE) United States $1.168B 0.00
AnaptysBio (ANAB) United States $1.129B 0.00
Innoviva (INVA) United States $1.111B 3.21
Athenex (ATNX) United States $1.089B 0.00
Zymeworks (ZYME) Canada $1.031B 0.00
Epizyme (EPZM) United States $1.015B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.986B 0.00
Cara Therapeutics (CARA) United States $0.918B 0.00
Twist Bioscience (TWST) United States $0.904B 0.00
ANI Pharmaceuticals (ANIP) United States $0.879B 14.69
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.856B 0.00
WAVE Life Sciences (WVE) Singapore $0.850B 0.00
Arvinas (ARVN) United States $0.828B 0.00
Principia Biopharma (PRNB) United States $0.821B 427.88
Pharming Group (PHGUF) Netherlands $0.811B 0.00
Cytokineticsorporated (CYTK) United States $0.773B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
UROGEN PHARMA (URGN) United States $0.742B 0.00
Anika Therapeutics (ANIK) United States $0.741B 26.21
ZIOPHARM Oncology Inc (ZIOP) United States $0.733B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.719B 25.96
Intellia Therapeutics (NTLA) United States $0.704B 0.00
Vericel (VCEL) United States $0.701B 0.00
Mesoblast (MESO) Australia $0.684B 0.00
Revance Therapeutics (RVNC) United States $0.621B 0.00
MiMedx (MDXG) United States $0.601B 0.00
DBV Technologies S.A (DBVT) France $0.581B 0.00
Heska (HSKA) United States $0.557B 72.15
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.532B 0.00
Retrophin (RTRX) United States $0.532B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.528B 0.00
Precision BioSciences (DTIL) United States $0.509B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.505B 0.00
Cellectis S.A (CLLS) France $0.503B 0.00
Stemline Therapeutics (STML) United States $0.495B 0.00
Intra-Cellular Therapies (ITCI) United States $0.482B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Syros Pharmaceuticals (SYRS) United States $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Merus (MRUS) Netherlands $0.438B 0.00
Puma Biotechnology (PBYI) United States $0.434B 0.00
BioDelivery Sciences (BDSI) United States $0.420B 0.00
Agenus (AGEN) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.417B 0.00
Arcus Biosciences (RCUS) United States $0.414B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Bellus Health (BLU) Canada $0.407B 0.00
Adverum Biotechnologies (ADVM) United States $0.398B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.367B 0.00
Protagonist Therapeutics (PTGX) United States $0.362B 0.00
AC Immune SA (ACIU) Switzerland $0.362B 26.80
Kadmon Holdings (KDMN) United States $0.350B 0.00
Gritstone Oncology (GRTS) United States $0.349B 0.00
Theratechnologies (THERF) Canada $0.340B 0.00
Prothena (PRTA) Ireland $0.340B 0.00
Avid Bioservices (CDMO) United States $0.331B 0.00
Scholar Rock Holding (SRRK) United States $0.323B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
ADMA Biologics Inc (ADMA) United States $0.311B 0.00
Kindred Biosciences (KIN) United States $0.301B 0.00
Sorrento Therapeutics (SRNE) United States $0.299B 0.00
Albireo Pharma (ALBO) United States $0.297B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Dynavax Technologies (DVAX) United States $0.287B 0.00
Geron (GERN) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
Clovis Oncology (CLVS) United States $0.266B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.261B 0.00
Senesco Technologies (ELOX) United States $0.253B 0.00
MannKind (MNKD) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.247B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.247B 0.00
Prometic Life Sciences (PFSCF) Canada $0.246B 0.00
PDL BioPharma (PDLI) United States $0.246B 6.32
Sutro Biopharma (STRO) United States $0.245B 0.00
Inovio Pharmaceuticals (INO) United States $0.241B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
POXEL SA FRANCE (PXXLF) France $0.228B 0.00
Affimed (AFMD) Germany $0.226B 0.00
Spero Therapeutics (SPRO) United States $0.226B 0.00
Compugen (CGEN) Israel $0.222B 0.00
Athersys (ATHX) United States $0.221B 0.00
EXICURE INC (XCUR) United States $0.219B 0.00
Kamada (KMDA) Israel $0.207B 7.89
Five Prime Therapeutics (FPRX) United States $0.200B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.197B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
XOMA (XOMA) United States $0.179B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.179B 0.00
Alcobra (ARCT) United States $0.176B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Acorda Therapeutics (ACOR) United States $0.163B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Novavax (NVAX) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.148B 6.09
Cerecor (CERC) United States $0.143B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.143B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.143B 0.00
Northwest Biotherapeutics (NWBO) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Emmaus Life Sciences (EMMA) United States $0.131B 0.00
NantKwest (NK) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Aptinyx (APTX) United States $0.126B 0.00
Menlo Therapeutics (MNLO) United States $0.120B 0.00
Fortress Biotech (FBIO) United States $0.115B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
Celyad SA (CYAD) Belgium $0.101B 0.00
Aduro Biotech (ADRO) United States $0.098B 0.00
Vaccinex (VCNX) United States $0.097B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.097B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.093B 0.00
Trevena (TRVN) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Arbutus Biopharma (ABUS) Canada $0.091B 0.00
Mersana Therapeutics (MRSN) United States $0.088B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.088B 0.00
VTv Therapeutics (VTVT) United States $0.086B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
Idera Pharmaceuticals (IDRA) United States $0.082B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.079B 0.00
Curis (CRIS) United States $0.075B 0.00
Liquidia Technologies (LQDA) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Catalyst Biosciences (CBIO) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Pluristem Therapeutics (PSTI) Israel $0.066B 0.00
Applied Genetic Technologies (AGTC) United States $0.066B 36.10
ASLAN Pharmaceuticals (ASLN) Singapore $0.063B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.061B 0.00
AquaBounty Technologies (AQB) United States $0.061B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Unum Therapeutics (UMRX) United States $0.059B 0.00
Stellar Biotechnologies (EDSA) Canada $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.049B 0.00
VBI Vaccines (VBIV) United States $0.048B 0.00
Oncobiologics (OTLK) United States $0.047B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
BIOCARDIA INC (BCDA) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Clearside Biomedical (CLSD) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
TOCAGEN INC (TOCA) United States $0.019B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Bionano Genomics (BNGO) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00